ERBB2 and breast neoplasm: Since some types of breast tumors are hormone-sensitive, a potential mechanism of lignans may be due to ER binding, but also via inhibition and downregulation of HER2 (human epidermal growth factor receptor 2) and EGFR (epidermal growth factor receptor) [54,55].